Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

M&G reports strong inflows as H1 profits hold steady

(Sharecast News) - M&G on Wednesday reported steady profits for the first half, though the investment manager saw strong net flows from open business. Adjusted operating profit before tax came in at £378m for the six months to 30 June, more or less unchanged from £375m the year before, as growth was held back by a £8m FX loss in asset management.

However, adjusted profit after tax jumped to £248m, from a £56m loss previously, due to a significant improvement in short-term fluctuations in investment returns and mismatches arising on application of IFRS 17, M&G said.

Net flows from open business totalled £2.1bn, a £3.2bn swing from the £1.1bn of outflows reported last year, helped by £2.6bn of net inflows from external clients in asset management.

"This growth has been supported by our market leading investment performance and continued international expansion," said chief executive Andrea Rossi.

"Today, 58% of our Asset Management third party [assets under management and administration] comes from International clients, up from 37% five years ago. This cements our position as a leading international active asset manager, with an established footprint in Europe and growing access to attractive Asian markets."

The interim dividend inched higher to 6.7p from 6.6p per share, in line with the dividend policy.

Looking ahead, M&G said it was confident in delivering its strategic priorities and financial targets, adding that the business is "well positioned navigate the current uncertain economic and geopolitical environment due to its diversified business model, international footprint, compelling products and services, investment capabilities and expertise".

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.